Inflammatory Bowel Diseases (IBD)

Clinical trials and research studies on inflammatory bowel diseases including ulcerative colitis and Crohn’s disease

Inflammatory bowel disease (IBD) is a chronic, serious intestinal inflammation that encompasses both ulcerative colitis and Crohn’s disease. Diagnosing IBD can be difficult and may be based on physical examinations, blood tests, x-rays, upper and lower gastrointestinal endoscopy, including colonoscopy.

People with inflammatory bowel diseases like ulcerative colitis and Crohn’s disease, can suffer daily from debilitating abdominal pain, diarrhea, rectal bleeding, weight loss and occasional joint pain. At the present time, no one knows f the causes of ulcerative colitis and Crohn’s disease and there are no cures. Fortunately there are several new and novel therapies now available through clinical trials by Long Island Clinical Research Associates (LICRA).

LICRA’s staff has been involved in the cutting edge of clinical trials in IBD since 1982. If you have been diagnosed with – or think that you may have – IBD, ulcerative colitis or Crohn’s disease you may want to consider being a part of one of our clinical trials. Our IBD clinical trials are fully supervised and observed by renowned physicians in the gastrointestinal field. By volunteering for our IBD clinical trials you will have the opportunity to try promising new treatments and help in the understanding of your condition. If you are eligible for our IBD clinical trials, all medications, examinations and laboratory tests are provided to you at no cost. Most clinical trials also include compensation for your time and traveling expenses.

Interested in participating in our IBD clinical trials and research studies?

If you would like to be a part of our clinical trials and research studies for IBD, ulcerative colitis or Crohn’s disease please contact us. We encourage you to read through our site to learn more about clinical trials and the highly qualified physicians that conduct all of our medical research studies. We look forward to serving you.